PTK2 and breast carcinoma: Enhanced c-Src activity is also one potential mechanism leading to tamoxifen-resistant growth in breast cancer, and activation of c-Src and Fak has a close relationship with distant recurrence in hormone-treated, ER-positive breast cancer [9].